- Agreement Negotiation & Signature
- Award Management
- Outgoing Subawards
This Instructional Guide will serve to assist campus with expectations on review, routing and set up of Clinical Trials (CTs) given that they may be executed by DSP-Gainesville (DSP), DSP-Jacksonville (JAX) or the UF Office of Clinical Research (OCR).
The original negotiating office will review and execute any amendments.
All new subawards are requested by campus through the Awards Module in UFIRST. Subawards requested for Awards in fund 201 and 209 will automatically route to DSP in UFIRST. Subawards requested for awards in fund 214 will automatically route to OCR. After approval by the DSP and OCR directors, subawards can be rerouted or assigned to a different office.
The University of Florida Subrecipient Risk Assessment Policy states, “The Federal Uniform Guidance (2 CFR 200.331b) requires all recipients of federal funds to “evaluate each subrecipient’s risk of noncompliance with Federal statutes, regulations, and the terms and conditions of the subaward for purposes of determining the appropriate subrecipient monitoring.” To comply with this requirement, the University will perform a risk assessment on all subrecipients receiving federal funds and subrecipients under non-federal sources of funds that are not fixed rate payments based on cases or events.
The Project Risk Assessment will be completed by the Office assigned to the Subaward.
UF Commitment Guidance (https://www.fa.ufl.edu/wp-content/uploads/2020/06/Commitment-Guidance.pdf) Subaward Risk Assessment Policy (https://generalcounsel.ufl.edu/regulations-and-policies/)
Subaward Risk Assessment Directives and Procedures (https://generalcounsel.ufl.edu/regulations-and-policies/)